Showing results (1-10 of 3,435) with videos related to
Sort By:
Pageof 344
Expert Opinion on Therapeutic Targets|February 9, 2012
Clinical trials and biomarker research on lung cancer in ChinaYi-long Wu, Qing ZhouJournal of Hematology & Oncology|October 12, 2012
Can EGFR-TKIs be used in first line treatment for advanced non-small cell lung cancer based on selection according to clinical factors? - A literature-based meta-analysisChongrui Xu, Qing Zhou, Yi-Long WuCancer Letters|June 16, 2019
Clinical management of third-generation EGFR inhibitor-resistant patients with advanced non-small cell lung cancer: Current status and future perspectivesYi-Chen Zhang, Qing Zhou, Yi-Long WuAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
Research and standard care: lung cancer in chinaTony S Mok, Qing Zhou, Yi-Long WuOncotarget|October 21, 2017
The resistance mechanisms and treatment strategies for <i>EGFR</i>-mutant advanced non-small-cell lung cancerWen-Zhao Zhong, Qing Zhou, Yi-Long WuExpert Opinion on Pharmacotherapy|July 1, 2016
Efficacy of crizotinib in first-line treatment of adults with ALK-positive advanced NSCLCYi-Chen Zhang, Qing Zhou, Yi-Long WuESMO Open|March 4, 2017
Emerging challenges of advanced squamous cell lung cancerYi-Chen Zhang, Qing Zhou, Yi-Long WuJournal of Hematology & Oncology|October 25, 2017
The emerging roles of NGS-based liquid biopsy in non-small cell lung cancerYi-Chen Zhang, Qing Zhou, Yi-Long WuExpert Opinion on Pharmacotherapy|April 25, 2015
Emerging paradigms in targeted treatments for Asian patients with NSCLCE-E Ke, Qing Zhou, Yi-Long WuTranslational Lung Cancer Research|March 26, 2015
Clinical trials for lung cancer in ChinaFei-Yu Niu, Wen-Zhao Zhong, Qing Zhou, et al.Pageof 344